OptoSeeker (追光生物)

OptoSeeker (Optoseeker Biotechnology (Shenzhen) Co., Ltd.) is a Shenzhen-based life-science instrument maker founded in 2023 and one of the few companies worldwide with proprietary optoelectronic tweezer (OET) core technology. Its OptoBot product line integrates OET, microfluidics, imaging and software for high-throughput single-cell manipulation and functional screening in antibody discovery, cell-line development and cell and gene therapy, with products delivered to multiple customers. The company also provides AI-oriented single-cell functional data services and has strategic partnerships with MGI Tech and BioMap.

  • Seed
  • AI/ML
  • Biotechnology
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Oct 8, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Oct 8, 2026

    CNY 50M

    Seed

    Led by Shenzhen Capital Group

    • Shenzhen Capital Group
    • Lingyi Venture Capital (零以创投)
    • Guangdong TCM Health Fund (广东中医药大健康基金)
    • 南山战新投 (Nanshan Strategic Emerging Industry Investment)

    Article coming soon.

Pricing

Research OptoSeeker (追光生物) — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if OptoSeeker (追光生物) is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational